跳到正文
原文
BioMarin· @BioMarin · X·· 12 天前AI 评分10
AI 导读

BioMarin连续第六年赞助LabCentral金门票计划,Orthrus Therapeutics获其赞助的金门票。Orthrus因展示一种有望实现对长期给药疗法持久免疫耐受的新方法而获奖,将获得LabCentral驻留资格及社区资源。

正文

Several of our team members were on hand in Cambridge, MA last week as local startups made their case for a @LabCentral Golden Ticket, which provides emerging biotechs with residency at LabCentral and access to its innovative community and resources. Orthrus Therapeutics took home the BioMarin-sponsored Golden Ticket after demonstrating a promising novel approach to help enable long-lasting immune tolerance to chronically administered therapies.

We’re proud to support Lab Central’s Golden Ticket program for the sixth consecutive year to celebrate collaboration in advancing the life sciences, and are excited to see how Orthrus Therapeutics contributes to the future of genetic medicine.

Learn more about the LabCentral Golden Ticket program: http://ms.spr.ly/6014afCyu

来源:BioMarin · x.com